The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Clinical Cancer Research|2020Cited by 86
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Estefanía Labanca et al.|Clinical Cancer Research|2024Cited by 28
Data from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Estefanía Labanca et al.|Unknown|2024Cited by 1
Supplementary Results from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0
Table S5 from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0